-
Mashup Score: 18Treatment Landscape of mCRPC "Presentation" - Matthew Rettig - 12 day(s) ago
At the 2024 UCSF-UCLA PSMA Conference, Matthew Rettig discusses the critical advancements and challenges in treating metastatic castration-resistant prostate cancer (mCRPC), highlighting the shift towards precision oncology with FDA-approved treatments like PARP inhibitors and Lutetium PSMA therapy, tailored to genetic mutations and PSMA PET imaging findings. Dr. Rettig emphasizes the importance…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 18Treatment Landscape of mCRPC "Presentation" - Matthew Rettig - 1 month(s) ago
At the 2024 UCSF-UCLA PSMA Conference, Matthew Rettig discusses the critical advancements and challenges in treating metastatic castration-resistant prostate cancer (mCRPC), highlighting the shift towards precision oncology with FDA-approved treatments like PARP inhibitors and Lutetium PSMA therapy, tailored to genetic mutations and PSMA PET imaging findings. Dr. Rettig emphasizes the importance…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 18Treatment Landscape of mCRPC "Presentation" - Matthew Rettig - 1 month(s) ago
At the 2024 UCSF-UCLA PSMA Conference, Matthew Rettig discusses the critical advancements and challenges in treating metastatic castration-resistant prostate cancer (mCRPC), highlighting the shift towards precision oncology with FDA-approved treatments like PARP inhibitors and Lutetium PSMA therapy, tailored to genetic mutations and PSMA PET imaging findings. Dr. Rettig emphasizes the importance…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
Magnitude: mb 4.9, Region: MENDOZA, ARGENTINA, Date time: 2021-06-23 23:20:40.3 UTC, Location: 32.89 S ; 69.10 W, Depth: 40 km.
Source: EMSC-CSEMCategories: Future of Medicine, Latest HeadlinesTweet
Interdisciplinary uro-oncology conference in #Mendoza. Mauricio Fernández Lázaro, MD discusses the @UroTarget conference focusing on the interdisciplinary management of uro-oncological pathologies > https://t.co/MfkfbUtQcd https://t.co/C27zrtiIvp